229 related articles for article (PubMed ID: 19688831)
1. Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
van Vliet MJ; Tissing WJ; Rings EH; Koetse HA; Stellaard F; Kamps WA; de Bont ES
Pediatr Blood Cancer; 2009 Dec; 53(7):1188-94. PubMed ID: 19688831
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for mucositis assessment.
Baggott C
Pediatr Blood Cancer; 2009 Dec; 53(7):1169-70. PubMed ID: 19731328
[No Abstract] [Full Text] [Related]
3. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
Lutgens LC; Blijlevens NM; Deutz NE; Donnelly JP; Lambin P; de Pauw BE
Cancer; 2005 Jan; 103(1):191-9. PubMed ID: 15573372
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients.
Lemez P; Urbánek V
Neoplasma; 2005; 52(5):398-401. PubMed ID: 16151584
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy for acute myelogenous leukemia.
Kalaycio M
Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
[No Abstract] [Full Text] [Related]
8. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
Petti MC; Avvisati G; Tafuri A; Meloni G; Amadori S; Mandelli F
Ann N Y Acad Sci; 1987; 511():436-41. PubMed ID: 3326472
[No Abstract] [Full Text] [Related]
9. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
10. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
11. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.
Jianfeng G; Weiming Z; Ning L; Fangnan L; Li T; Nan L; Jieshou L
J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
Kolitz JE; George SL; Baer MR; Lee EJ; Bloomfield CD; Larson RA;
Ann Hematol; 2004; 83 Suppl 1():S103-4. PubMed ID: 15124695
[No Abstract] [Full Text] [Related]
14. Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.
Chim CS; Kwong YL
Am J Hematol; 1996 Nov; 53(3):208. PubMed ID: 8895701
[No Abstract] [Full Text] [Related]
15. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.
Picot D; Garin L; Trivin F; Kossovsky MP; Darmaun D; Thibault R
Clin Nutr; 2010 Apr; 29(2):235-42. PubMed ID: 19744750
[TBL] [Abstract][Full Text] [Related]
16. Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients.
Lutgens LC; Deutz N; Granzier-Peeters M; Beets-Tan R; De Ruysscher D; Gueulette J; Cleutjens J; Berger M; Wouters B; von Meyenfeldt M; Lambin P
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):275-85. PubMed ID: 15337566
[TBL] [Abstract][Full Text] [Related]
17. Lactose maldigestion during methotrexate-induced gastrointestinal mucositis in a rat model.
Fijlstra M; Rings EH; Verkade HJ; van Dijk TH; Kamps WA; Tissing WJ
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G283-91. PubMed ID: 21088238
[TBL] [Abstract][Full Text] [Related]
18. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy does not influence intestinal amino acid uptake in children.
de Koning BA; van der Schoor SR; Wattimena DL; de Laat PC; Pieters R; van Goudoever JB
Pediatr Res; 2007 Aug; 62(2):195-9. PubMed ID: 17597661
[TBL] [Abstract][Full Text] [Related]
20. Citrulline and intestinal fatty acid-binding protein: longitudinal markers of postweaning small intestinal function in pigs?
Berkeveld M; Langendijk P; Verheijden JH; Taverne MA; van Nes A; van Haard P; Koets AP
J Anim Sci; 2008 Dec; 86(12):3440-9. PubMed ID: 18708596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]